[Disseminated intravascular coagulation syndrome (DIC) in stomach and intestinal cancer].
Hemostasis was studied in 70 patients with gastric or intestinal cancer. Pronounced imbalance in blood coagulation was established, resulting in chronic disseminated intravascular coagulation (DIC) syndrome in 55.7 and thrombophilia--in 20% of cases. Advancement of tumor to stage IV was followed by development of stage II (subacute) DIC syndrome. The syndrome was frequently manifested by thrombohemorrhagic complications which occurred in 14.5% of cancer patients (autopsy data). It was inferred that timely treatment of malignancies, early administration of heparin, fibrinolysis--activating drugs and deaggregants are pathogenetically justified means for prevention and treatment of DIC syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D003131:Combined Modality Therapy; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000209:etiology*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000097:blood / Q000209:etiology; D006487:Hemostasis; D006801:Humans; D007414:Intestinal Neoplasms / Q000097:blood / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000097:blood / Q000150:complications* / Q000628:therapy; D013927:Thrombosis / Q000097:blood / Q000209:etiology; D013997:Time Factors
Sindrom disseminirovannoĭ vnutrisosudistoĭ svertyvaemosti (DVS) pri rake zheludka i kishechnika.